Blog

All MedBen Clients Can Benefit from Rx Solutions

MedBen Rx offers employers a better way to provide and manage prescription benefits, regardless of their size or industry type. Our pharmacy solutions counter inflated prescription list prices with common-sense reimbursement methods. Self-funded employers can take...

read more

Government Fixes to Rx Prices a Slippery Slope

A recent Wall Street Journal editorial warns that government efforts to address prescription drug prices could produce undesirable consequences… and it's why MedBen Rx believes that market-driven solutions are the preferable method to reducing consumer costs. As the...

read more

Biggest? Nope. Best? That’s the Goal.

High-profile health care companies continue to buy each other in an effort to be “biggest and best.” Meanwhile, MedBen continues to grow as it has for over 80 years... by providing clients with superior benefits management services. A quick recap: Anthem Health will...

read more

Fight Back Against New Year’s Drug Price Increases

New year, higher drug prices. According to The Wall Street Journal, a representative analysis of major pharmaceutical companies found that the prices of their brand name and generic drugs have risen by an average of 6.3% in 2019 – modest compared to previous years,...

read more

AWP Smoke and Mirrors

Drug pricing can be a confusing business… and much of the confusion stems from a drug’s average wholesale price, or AWP. On the surface, the AWP might seem to be… well, the average wholesale price or the average price of a drug. But the price to who? As...

read more

MedBen Rx Tackles Brand-Name Increases

Modern Healthcare recently highlighted the growing disparity between brand-names and generics in relation to prescription drug spending. A new study finds that while total spending on generic drugs has declined, branded prescription drug spending continues to rise. In...

read more

The Clear Solution to Rx Spending Trends

A New York Times article examines the dramatic rise in U.S. prescription drug costs over the past two decades. American drug spending was once on par with other wealthy countries, but between 1997 and 2007 our drug spending tripled... and took off again in 2013. How...

read more

Generic Drugs: Effective and Cost-Efficient

As the prescribing of generic drugs has become more commonplace, most consumers have come to see that these medications work just as well as their pricier band-name equivalents. Indeed, when a generic alternative is available, MedBen clients see a 98% average...

read more

MedBen Rx Solutions Put Transparency Up Front

In an effort to improve drug pricing transparency, the Department of Health and Human Services recently released a proposal requiring drug companies to include their list prices in consumer ads. But MedBen already provides far more transparent Rx solutions. Drug...

read more

MedBen Fights Back Against PBM Spread Pricing

Spread pricing is a little-discussed aspect of prescription drug pricing, but its impact on pharmacy plan costs can be huge… and it’s why MedBen has responded with new pharmacy programs designed to remove spread pricing from the cost equation altogether. Simply...

read more

PBMs, PSAs, and Your Pharmacy Costs

To people outside the health care industry, the role of the pharmacy benefits manager (PBM) can be a bit unclear. Simply stated, PBMs act as intermediaries between insurers (or, in the case of self-funded plans, employers), drug companies, pharmacies, and consumers....

read more